Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Insulet

Insulet Corporation Stock: Is PODD Underperforming the Healthcare Sector?

Insulet Corporation has underperformed the healthcare sector over the past year. However, analysts remain strongly bullish about its prospects.

Barchart · Jun 19

Are Wall Street Analysts Bullish on Insulet Stock?

Although Insulet has lagged the broader market over the past year, Wall Street analysts remain strongly optimistic about the company’s long-term growth prospects.

Barchart · May 25

Is Insulet Stock Underperforming the Dow?

Insulet has underperformed the Dow recently, yet analysts remain highly optimistic about the stock’s prospects.

Barchart · Mar 21

From analysis to the latest developments in health,
read the most diverse news in one place.

What Are Wall Street Analysts' Target Price for Insulet Stock?

Insulet has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.

Barchart · Feb 18

What You Need To Know Ahead of Insulet’s Earnings Release

Here’s what analysts are expecting from the underperforming stock Insulet prior to its Q4 earnings.

Barchart · Jan 22

Is Insulet Stock Underperforming the Nasdaq?

Although Insulet has underperformed the Nasdaq recently, analysts remain highly optimistic about the stock’s prospects.

Barchart · Dec 16, 2025

Insulet Stock: Is Wall Street Bullish or Bearish?

Insulet has outperformed the broader market over the past year, and analysts remain strongly bullish on the company’s trajectory.

Barchart · Nov 20, 2025

Read news from The Economist, FT, and more,
with one subscription

Is Insulet Stock Outperforming the S&P 500?

Insulet has outperformed the S&P 500 over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart · Sep 24, 2025

Insulet Stock: Analyst Estimates & Ratings

Insulet has significantly outpaced the broader market over the past year, and analysts remain very bullish on the stock’s prospects.

Barchart · Aug 26, 2025

Cisco, Rocket Companies, Insulet And More On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said he remains long on Rocket Companies, Inc. (NYSE:RKT).

Benzinga · Aug 20, 2025

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Insulet Corporation (NASDAQ:PODD) reported second-quarter adjusted earnings of $1.17 per share, beating the consensus of 92 cents.

Benzinga · Aug 7, 2025

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart · Jun 24, 2025

3 Medical Technology Stocks Outperforming in 2025

Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.

MarketBeat · Jun 9, 2025

Do Wall Street Analysts Like Insulet Stock?

Insulet has significantly outpaced the broader market over the past year, and analysts remain bullish on the stock’s prospects.

Barchart · May 23, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · May 14, 2025

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.

Barchart · Apr 28, 2025

Here's What to Expect From Insulet's Next Earnings Report

Insulet is set to release its first-quarter results next month, and analysts expect a double-digit earnings growth.

Barchart · Apr 1, 2025

Insulet Stock: Is PODD Outperforming the Healthcare Sector?

As Insulet has outperformed relative to the healthcare sector over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart · Feb 25, 2025

Insulet Stock Outlook: Is Wall Street Bullish or Bearish?

Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Jan 27, 2025

Earnings Preview: What to Expect From Insulet's Report

Insulet is scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit decline.

Barchart · Dec 27, 2024

Is Insulet Stock Outperforming the Dow?

Insulet has outperformed the Dow recently, and analysts remain strongly optimistic about the stock’s prospects.

Barchart · Nov 27, 2024

Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink?

As Insulet outperformed relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

International Business Times · Nov 19, 2024

Dexcom Glucose Data To Be Integrated With ŌURA Rings

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.

The Conversation · Oct 16, 2024

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

Barchart · Sep 24, 2024

Is Insulet Stock Outperforming the Nasdaq?

Insulet has outperformed the Nasdaq Composite over the past year and analysts remain strongly bullish about the stock’s prospects.

Barchart · Aug 28, 2024

Stocks Close in the Red, Nvidia Trades Lower After Earnings Report

The Nasdaq 100 fell to a 2-week low on Wednesday, dragging down the broader market. Nvidia stock drops after the AI company released its earnings report.

1 2 3

Coverage From

People

Joshua Brown

38 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.